Ivan Tornos on reimbursement
From When You Are the Boldest... · · Mullings Group
“Your reimbursement every day goes down. For the last 23, 25 years, you're making less money.”
On , Ivan Tornos, President, CEO & Chairman of the Board at Zimmer Biomet Holdings Inc, spoke about reimbursement during When You Are the Boldest... on Mullings Group.
About Ivan Tornos
Ivan Tornos, President, CEO and Chairman of Zimmer Biomet, has described the company as undergoing a transformation from a legacy product company to a technology company. In public appearances throughout 2025, Tornos stated that the company is disrupting its strategy, operations, and culture while keeping its purpose of alleviating pain unchanged. He highlighted the company’s focus on autonomous robotics, smart implants, data algorithms, and remote surgery capabilities, including a partnership with Monogram Technologies for fully autonomous procedures and a collaboration with Microsoft for mixed-reality guided surgeries. Tornos also noted that Zimmer Biomet plans to launch 50 new products over 36 months and that 40 to 60 percent of orthopedic cases are expected to shift to ambulatory surgical centers. Tornos has emphasized the importance of patient awareness, citing that 600 million people suffer from arthritis but fewer than 5 percent seek treatment. He discussed a partnership with Arnold Schwarzenegger, who serves as Chief Wellness Officer, to educate patients about